Clinical Trials at Eminence
During the past decade, Eminence conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Eminence"
#1 collaborator was "Cadila Pharnmaceuticals" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Heart and Stroke Foundation of Ontario" with 1 trials as a collaborator, "University of California, Davis" with 1 trials as a collaborator and "Wellcome Trust" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Eminence
According to Clinical.Site data, the most researched conditions in "Eminence" are
"Cancers" (1 trials), "Cardiovascular Disease" (1 trials), "Fractures" (1 trials) and "Malnutrition" (1 trials). Many other conditions were trialed in "Eminence" in a lesser frequency.
Clinical Trials Intervention Types at Eminence
Most popular intervention types in "Eminence" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (1 trials), "Improve Early Breastfeeding" (1 trials), "Matching Placebo" (1 trials), "Polycap" (1 trials) and "Vitamin D" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Eminence
The vast majority of trials in "Eminence" are
2 trials for "All" genders.
Clinical Trials Status at Eminence
Currently, there are NaN active trials in "Eminence".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Eminence,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Eminence, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".